M11.139
Familial chondrocalcinosis, unspecified wrist
Clinical Classification Guidelines
Medical Intelligence & Overview
Familial chondrocalcinosis, also known as calcium pyrophosphate deposition disease, is a condition characterized by the buildup of calcium pyrophosphate crystals in the cartilage of joints. When it affects the wrist and occurs within a family, it is termed familial chondrocalcinosis of the wrist. This condition can cause joint pain, stiffness, and swelling, impacting daily activities and overall joint health. It is often diagnosed through clinical evaluation and imaging studies and may require ongoing management to control symptoms and prevent joint damage.
Causes & Symptoms
Clinical Causes: Genetic predisposition: inheritance of genes that lead to abnormal calcium metabolism or cartilage structure Age-related changes: increased likelihood with advancing age Metabolic disorders: such as hyperparathyroidism, hemochromatosis, or hypophosphatasia Environmental factors: mechanical stress or injury to the wrist joint
Key Symptoms: Joint pain that may be sudden or persistent Swelling and tenderness in the wrist Reduced range of motion and stiffness, especially after periods of inactivity Presence of chalky deposits felt as lumps or nodules around the joint Possible warmth or redness over the affected area
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical examination, patient history, imaging studies, and laboratory tests. Key diagnostic steps include: - Imaging: X-rays or ultrasound can reveal calcium deposits in the cartilage or surrounding tissues. - Joint aspiration: extracting joint fluid to identify calcium pyrophosphate crystals under polarized light microscopy. - Blood tests: to rule out other metabolic or inflammatory conditions. - Family history assessment: understanding genetic predisposition. Confirming familial chondrocalcinosis of the wrist helps tailor treatment strategies and provides insights into disease progression.
Treatment Protocols: Management of familial chondrocalcinosis focuses on alleviating symptoms and minimizing joint damage. Common approaches include: - Nonsteroidal anti-inflammatory drugs (NSAIDs): to reduce pain and inflammation. - Colchicine: may be prescribed to prevent flare-ups. - Corticosteroid injections: to control severe inflammation within the joint. - Physical therapy: to improve joint function and strength. - Lifestyle modifications: including activity adjustments and applying heat or cold therapy. - Monitoring and managing underlying metabolic issues: such as controlling calcium and mineral levels. Surgical intervention is rarely necessary but may be considered in cases of severe joint damage requiring joint replacement or debridement. Regular follow-up with healthcare providers is essential for ongoing management and monitoring of disease progression.
Clinical Advice & FAQs
Billing Guidance
Is M11.139 a billable ICD-10 code?
Yes, M11.139 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.139?
Clinical documentation must specify the nature of Familial chondrocalcinosis, unspecified wrist and any associated comorbidities for accurate reporting.
Cite this Clinical Reference